partial epilepsy
Conditions
Interventions
The dosage in the vain of [C-11]ITMM for PET/CT imaging.
Sponsors
Tokoyo Metropolitan Institute of Gerontology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed as having epilepsy. 2. Parients being suspected of partial seizure based on seizure symptoms, brain MRI and FDG-PET findings. 3. Patients with documented agreement on the informed consent by themselves or by their legally acceptable representatives.
Exclusion criteria
Exclusion criteria: 1. Patients who are suspected of generalized seizure. 2. Patients accompanied by chronic renal failure. 3. Pregnant women or possible pregnant women. 4. The patient who judged by the clinical investigator to be inappropriate as a participant in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Distribution of C-11 ITMM in epileptic foci Date of evaluation: on the day of PET scan | — |
Secondary
| Measure | Time frame |
|---|---|
| Distribution of C-11 flumazenil in epileptic foci Date of evaluation: on the day of PET scan | — |
Countries
Japan
Contacts
Public ContactKenji Ishii
Tokyo Metropolitan Institute of Gerontology Research Team for Neuroimaging
Outcome results
None listed